PCV11- THE COST-EFFECTIVENESS OF LEVOSIMENDAN IN SEVERE LOW-OUTPUT HEART FAILURE COMPARED TO DOBUTAMINE BASED ON AN INTERNATIONAL CLINICAL TRIAL (LIDO)

Sep 1, 2001, 00:00
10.1016/S1098-3015(11)71713-2
https://www.valueinhealthjournal.com/article/S1098-3015(11)71713-2/fulltext
Title : PCV11- THE COST-EFFECTIVENESS OF LEVOSIMENDAN IN SEVERE LOW-OUTPUT HEART FAILURE COMPARED TO DOBUTAMINE BASED ON AN INTERNATIONAL CLINICAL TRIAL (LIDO)
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71713-2&doi=10.1016/S1098-3015(11)71713-2
First page :
Section Title :
Open access? : No
Section Order : 228
Categories :
Tags :
Regions :
ViH Article Tags :